Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib with Carboplatin and Docetaxel in Advanced NSCLC
NCT00647426Phase 2Completed
- Sponsor
- Abramson Cancer Center
- Start
- Nov 2007
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in non-small cell lung cancer (NSCLC), sponsored by Abramson Cancer Center. Started Nov 2007; status: completed.
02
Drugs
sorafenib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00647426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00647426.